224 related articles for article (PubMed ID: 25403491)
1. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis.
Nobakht M Gh BF; Aliannejad R; Rezaei-Tavirani M; Taheri S; Oskouie AA
Biomarkers; 2015 Feb; 20(1):5-16. PubMed ID: 25403491
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in exhaled breath condensate as fingerprints of asthma, chronic obstructive pulmonary disease and asthma-chronic obstructive pulmonary disease overlap: a critical review.
Seyfinejad B; Nemutlu E; Taghizadieh A; Khoubnasabjafari M; Ozkan SA; Jouyban A
Biomark Med; 2023 Oct; 17(19):811-837. PubMed ID: 38179966
[TBL] [Abstract][Full Text] [Related]
3. Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases.
Abrami M; Biasin A; Tescione F; Tierno D; Dapas B; Carbone A; Grassi G; Conese M; Di Gioia S; Larobina D; Grassi M
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339210
[TBL] [Abstract][Full Text] [Related]
4. Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.
Louhelainen N; Myllärniemi M; Rahman I; Kinnula VL
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):585-603. PubMed ID: 19281076
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Potential Role of Metabolomics in COPD: A Concise Review.
Tirelli C; Mira S; Belmonte LA; De Filippi F; De Grassi M; Italia M; Maggioni S; Guido G; Mondoni M; Canonica GW; Centanni S
Cells; 2024 Mar; 13(6):. PubMed ID: 38534319
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Imaging of Lung Perfusion.
Triphan SMF; Bauman G; Konietzke P; Konietzke M; Wielpütz MO;
J Magn Reson Imaging; 2024 Mar; 59(3):784-796. PubMed ID: 37466278
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic and metallomic profile differences between Veterans and Civilians with Pulmonary Sarcoidosis.
Banoei MM; Iupe I; Bazaz RD; Campos M; Vogel HJ; Winston BW; Mirsaeidi M
Sci Rep; 2019 Dec; 9(1):19584. PubMed ID: 31863066
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of common protein biomarkers involved in the pathogenesis of respiratory diseases with proteomic methods: A systematic review.
Rezaeeyan H; Arabfard M; Rasouli HR; Shahriary A; Gh BFNM
Immun Inflamm Dis; 2023 Nov; 11(11):e1090. PubMed ID: 38018577
[TBL] [Abstract][Full Text] [Related]
9. Microsensor arrays for saliva diagnostics.
Walt DR; Blicharz TM; Hayman RB; Rissin DM; Bowden M; Siqueira WL; Helmerhorst EJ; Grand-Pierre N; Oppenheim FG; Bhatia JS; Little FF; Brody JS
Ann N Y Acad Sci; 2007 Mar; 1098(1):389-400. PubMed ID: 17435144
[TBL] [Abstract][Full Text] [Related]
10. A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma.
Turi KN; Romick-Rosendale L; Ryckman KK; Hartert TV
J Allergy Clin Immunol; 2018 Apr; 141(4):1191-1201. PubMed ID: 28479327
[TBL] [Abstract][Full Text] [Related]
11. Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory Diseases.
Bisserier M; Sun XQ; Fazal S; Turnbull IC; Bonnet S; Hadri L
Cells; 2022 Mar; 11(6):. PubMed ID: 35326434
[TBL] [Abstract][Full Text] [Related]
12. A new metabolomics analysis technique: steady-state metabolic network dynamics analysis.
Cakmak A; Qi X; Cicek AE; Bederman I; Henderson L; Drumm M; Ozsoyoglu G
J Bioinform Comput Biol; 2012 Feb; 10(1):1240003. PubMed ID: 22809304
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics Applied to Pediatric Asthma: What Have We Learnt in the Past 10 Years?
Ferraro VA; Zanconato S; Carraro S
Children (Basel); 2023 Aug; 10(9):. PubMed ID: 37761413
[No Abstract] [Full Text] [Related]
14. Dextran-based Drug Delivery Approaches for Lung Diseases: A Review.
Kumari M; Sharma S; Kanwar N; Naman S; Baldi A
Curr Drug Deliv; 2024 Jan; ():. PubMed ID: 38243938
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Fingerprint of Chronic Obstructive Lung Diseases: A New Diagnostic Perspective.
Tsoukalas D; Sarandi E; Thanasoula M; Docea AO; Tsilimidos G; Calina D; Tsatsakis A
Metabolites; 2019 Nov; 9(12):. PubMed ID: 31779131
[TBL] [Abstract][Full Text] [Related]
16. Exploring Biomarkers in Asthma: Insights From Serum Metabolomics.
Kim J; Shin HW
Allergy Asthma Immunol Res; 2024 May; 16(3):211-213. PubMed ID: 38910279
[No Abstract] [Full Text] [Related]
17. Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases.
Adamko DJ; Nair P; Mayers I; Tsuyuki RT; Regush S; Rowe BH
J Allergy Clin Immunol; 2015 Sep; 136(3):571-580.e3. PubMed ID: 26152317
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers to predict asthma in wheezing preschool children.
Bannier MA; van de Kant KD; Jöbsis Q; Dompeling E
Clin Exp Allergy; 2015 Jun; 45(6):1040-50. PubMed ID: 25409553
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic Endotype of Asthma.
Comhair SA; McDunn J; Bennett C; Fettig J; Erzurum SC; Kalhan SC
J Immunol; 2015 Jul; 195(2):643-50. PubMed ID: 26048149
[TBL] [Abstract][Full Text] [Related]
20. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.
Bowler RP; Jacobson S; Cruickshank C; Hughes GJ; Siska C; Ory DS; Petrache I; Schaffer JE; Reisdorph N; Kechris K
Am J Respir Crit Care Med; 2015 Feb; 191(3):275-84. PubMed ID: 25494452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
